The Administration's Drug Rebate Proposal:

An Opportunity to Put Patients First

February 2019 – The Morning Consult has published an opinion-editorial co-authored by A. Mark Fendrick, MD, V-BID Center Director, and Dan Klein, President & CEO of the PAN Foundation, recommending that patients be the first to benefit from the Trump Administration’s proposal to reallocate rebates paid by drug companies.

Read the Full Article

To learn more about value-based drug pricing, view the resources below:

Drug Price Iceberg Initiative Page
Drug Price Iceberg Infographic
Drug Price Iceberg 1-Pager